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Abstract Mycoplasma contamination is a major
problem in cell culturing, potentially altering the
results of cell line-based experiments in largely
uncharacterized ways. To define the consequences of
mycoplasma infection at the level of protein expres-
sion we utilized the reverse phase protein array
technology to analyze the expression of 235 proteins
in mycoplasma infected, uninfected post treatment,
and never-infected leukemic cell lines. Overall, pro-
tein profiles of cultured cells remained relatively
stable after mycoplasma infection. However, paired
comparisons for individual proteins identified that
18.7% of the proteins significantly changed between
the infected and the never-infected cell line samples,
and that 14.0% of the proteins significantly altered
between the infected and the post treatment samples.
Six percent of the proteins were affected in the post
treatment samples compared to the never-infected
samples, and 7.2% compared to treated cells that had
never had mycoplasma infection before. Proteins that
were significantly altered in the infected cells were
enriched for apoptotic signaling processes and auto-
phosphorylation, suggesting an increased cellular
stress and a decreased growth rate. In conclusion, this
study shows that mycoplasma infection of leukemic
cell lines alters the proteins expression levels, poten-
tially confounding experimental results. This rein-
forces the need for regular testing of mycoplasma.
Keywords Mycoplasma  RPPA  Cell lines 
Proteomics
Introduction
Mycoplasma contamination of cell lines is one of the
major problems of cell culturing, with infection
present in 5–30% of the cell lines, despite significant
improvements in diagnostic and therapeutic possibil-
ities to detect and eliminate mycoplasma contamina-
tion (Drexler and Uphoff 2002; Drexler et al. 2017;
Uphoff and Drexler 2002). Because mycoplasmas lack
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a cell wall, their flexibility enables them to pass
through anti-bacteriological filters which facilitates
the contamination of media and cell cultures. The lack
of a cell wall also allows direct and tight contact with
the host cytoplasmic membrane that may result in cell
fusion (Drexler and Uphoff 2002; Nikfarjam and
Farzaneh 2012; Rottem and Barile 1993). Myco-
plasma infected cell cultures frequently cause further
spreading of contamination by the ease of droplet
formation during sample handling (Drexler and Uph-
off 2002). In contrast to bacteria and fungi, mycoplas-
mas grow relatively slowly and do not cause acute
cellular damage. They are resistant to most of the
commonly used antibiotics (Drexler and Uphoff 2002;
Nikfarjam and Farzaneh 2012). Therefore, mycoplas-
mas can live on the surface of eukaryotic host cells for
an extended period of time (Miller et al. 2003; Zhang
et al. 2000). Moreover, the mycoplasmas genome
lacks the ability to provide for their ownmetabolism or
replication which makes them dependent on their host
cells for survival. This dependency leads to competi-
tion for nutrients (e.g. arginine which is needed for
protein synthesis of the host), which can disrupt cell
integrity and in turn alter the host cell function (Miller
et al. 2003; Rottem and Barile 1993). Additionally, as
histone modification is reliant on arginine, arginine
depletion is thought to disrupt histone synthesis and so
influences gene regulation (Rottem and Barile 1993;
Rottem and Naot 1998).
As leukemic cell line experiments are an essential
tool to gain biological knowledge, it is important to
know the consequences of mycoplasma contamination
and to establish stable and reproducible cell cultures.
A study by Miller et al. (2003) already showed that
mycoplasma infection alters gene expression of hun-
dreds of genes in cultured human cells, and Gedye
et al. (2016) reported poorly reproducible results from
an aliquot of a cell line that was later found to be
infected with Mycoplasma hyorhinis. However, lim-
ited knowledge is available on the effects of
mycoplasma on protein expression. In this study we
determined protein expression levels of 235 proteins
in mycoplasma infected and non-infected cell lines
along with post treatment mycoplasma-free versions




Leukemic cell line samples (n = 52) derived from
either pediatric or adult AML (e.g. Kasumi-1, HL-60,
OCIAML3), ALL (e.g. Jurkat, REH), CML (e.g.
KBM5) and lymphoma (e.g. Raji) including various
molecular modifications were obtained from different
laboratories. Cell lines underwent Short Tandem
Repeat DNA fingerprinting for cell line identity
confirmation and were cultured according to the
ATCC cell culture methods. All cell lines were tested
for mycoplasma using the mycoplasma Polymerase
Chain Reaction (PCR) detection kit (Applied Biolog-
ical Materials Inc., Richmond, BC, Canada, Catalog
No. G238). Of these, 16 were positive for mycoplasma
infection and from these a sample was collected for
protein isolation for the ‘‘infected’’ samples. Infected
cell lines were then treated with 25 lg/mL Plas-
mocinTM Treatment (InvivoGen, San Diego, CA,
USA, Catalog# ant-mpt, version# 15B23-MM) for
2 weeks, and PCR was repeated immediately post
treatment to check their mycoplasma status. Cell
cultures that were successfully treated (all except one),
were then cultured for another 2–4 weeks and again
tested by PCR to verify if cell lines remained negative
during culturing. From each cell line culture cells were
collected for the production of protein for the ‘‘post
treatment’’ sample from this * 4-week sample. As it
is conceivable that mycoplasma infection could have
permanent effects on cell line protein expression
patterns, we attempted to assess this by obtaining
another sample of the same cell lines, that had never
had a mycoplasma infection, as best as we could
ascertain, for comparison. Those cell lines were
cultured similarly and checked by PCR on myco-
plasma before preparation of protein sample from the
‘‘never-infected’’ sample. For three infected cell lines,
no never-infected counterpart could be found. In
addition, to assess the effect of PlasmocinTM treatment
on protein expression, four never-infected cell lines
were treated and added to the array. In summary, a
total of 52 samples were available for comparison of
protein expression between the different mycoplasma
states; twelve cell lines had a complete set of an
infected, an uninfected post treatment and a never-
infected sample, one cell line had an infected and
never-infected sample, three cell lines had an infected
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and post treatment sample, and four cell lines that had
a never-infected and post treatment sample that had
never been infected before. More information regard-
ing the cell lines, including type, mycoplasma status,
disease and culture method are provided in Supple-
mental Table S1.
Reverse phase protein array methodology
RPPA was used to determine the protein expression of
52 leukemic cell line samples and ten normal CD34?
bone marrow samples. Methods and antibody valida-
tion techniques are fully described in previous publi-
cations (Kornblau et al. 2009, 2010; Tibes et al. 2006).
Briefly, whole cell lysate protein preparations were
prepared and normalized to a concentration of
1 9 104 cell/lL and printed in five serial (1:2)
dilutions onto slides along with normalization and
expression controls. Slides were probed with 235
strictly validated antibodies and a secondary antibody
to amplify the signal (Hunyady et al. 1996), and finally
a stable dye was precipitated. A ‘‘Rosetta Stone’’ of
manufacturer, antibody name (HUGO andMiMI), and
primary and secondary antibody dilution can be found
in Supplementary Table S2. The stained slides were
analyzed using Microvigene Software (Vigene Tech,
Carlisle, MA, USA) to produce quantified data.
Data normalization
SuperCurve algorithms were used to generate a single
value from the five serial dilutions (Hu et al. 2007).
Loading controls (Neeley et al. 2009) and topograph-
ical normalization (Neeley et al. 2012) procedures
were performed to account for protein concentration
and background staining variations. Since all samples
had replicates, the average expression level of the
replicates was used as a single expression level. All
protein expression levels were shifted relative to the
median of the normal CD34? bone marrow samples.
Statistical procedure
The unsupervised hierarchical clustering procedure
was performed using the Ward-linkage rule. Principal
component analysis was employed to further visualize
the distribution of each cell line in relation to their
mycoplasma status. Paired Wilcoxon signed-rank test
was applied to compare protein expression of
individual proteins between the three sample condi-
tions [infected vs. never-infected (n = 13), infected vs.
uninfected post treatment (n = 15), never-infected vs.
uninfected post treatment (n = 12)]. To compare
changes in protein expression between the never-
infected versus samples post treatment that were never
infected before (n = 4), we applied the Student’s t test,
because the Wilcoxon signed-rank test could not be
used for too small numbers of paired samples. All
statistical analyses were performed using R (Version
1.0.136 2009–2016 RStudio, Inc., Boston, MA,
USA).
Gene ontology enrichment analysis
Protein names were uploaded in the Database for
Annotation, Visualization and Integrated Discovery
version 6.8 and analyzed for gene ontology of
biological processes. Biological processes that were
significantly enriched (false-discovery rate corrected
q-value\ 0.05) were selected.
Results and discussion
Protein expression levels for all 235 antibodies were
determined and compared between the four subsets of
samples; infected, uninfected post treatment, never-
infected, and post treatment samples from cells that
were never infected before. Globally, based on
unbiased hierarchical clustering there was no segre-
gation of the infected samples from the uninfected post
treatment or the never-infected samples, as the differ-
ent samples from a given cell line tended to co-
segregate regardless of mycoplasma status (Fig. 1).
However, three outliers were observed between the
never-infected and infected samples compared to the
post treatment samples (e.g. RS4;11, ML-2 and U937),
suggesting that antibiotic treatment can affect the
protein profiles of the cell lines more than mycoplasma
infection in at least some cases. Moreover, when the
expression levels of individual proteins were assessed
with respect to mycoplasma infection status, several
proteins showed changes in their expression as shown
in Table 1. Most differences were observed between
the infected cells and either the uninfected post
treatment state (n = 33/235, 14.0%) or the never-
infected state (n = 44/235, 18.7%). Fewer alterations
were observed between the never-infected cells and
123
Cytotechnology (2018) 70:1529–1535 1531
the uninfected post treatment cells (n = 14/235, 6.0%)
and between the never-infected cells and the same post
treatment cells (n = 17/235, 7.2%). Most of the
proteins that exhibited significant alterations in the
infected cells had lower protein expression levels in
the infected samples compared to the never-infected
samples (n = 39/44, 88.6%) and compared to the post
treatment samples (n = 32/33, 97.0%). A significant
part of the proteins with altered expression in the
mycoplasma infected cell lines were similarly affected
A B
Fig. 1 Relative protein expression levels for the cell line
samples indicating their mycoplasma status. a Heatmap com-
paring overall protein expression for all cell line samples
relative to the normal CD34? cells. Each row represents an
individual protein and each column shows one cell line sample.
Annotation bar: infected (green), never-infected (blue), and post
treatment (red). b Principal component analysis for all 52
samples does not show separation based on mycoplasma status.
(Color figure online)
Table 1 Paired comparisons of protein expression for individual proteins
# Significantly different proteins between the sample conditions
Comparison Number of paired
samples
Number of affected proteins (%)
Infected versus post treatment 15 33 (14.0)
Infected versus never-infected 13 44 (18.7)
Never-infected versus post treatment 12 14 (6.0)
Never-infected versus post treatment without any mycoplasma
history
4 17 (7.2)
Cell lines for which more than one protein sample was collected were used to assess differences in proteins expression due to
mycoplasma status
123
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compared to both the uninfected post treatment
samples and the never-infected samples (19 of 44 for
infected vs. never-infected and 19 of 33 for infected
vs. uninfected post treatment), suggesting a core set of
mycoplasma infection altered proteins (Fig. 2). The
frequency with which protein levels differed between
the various conditions were all above 5%, the expected
false positive rate for that p value. These observations
are in line with our expectations based on the mRNA
literature (Miller et al. 2003) that we expected to find
differences between the four sample conditions, due to
the effect of mycoplasma infection, and we suspected
that we would also observe a residual effect of the
treatment to eradicate mycoplasma on the cells. All
significantly altered proteins together with their
median expression are listed in Supplemental
Table S3.
To then globally assess the effect of mycoplasma on
the cell biology, pathway analysis was performed for
the gene ontology (GO) biological processes (Fig. 3a–
c). Proteins that were changed in the infected samples
compared to the never-infected samples were primar-
ily involved in the apoptotic processes as well as in
protein auto-phosphorylation and germ cell develop-
ment. Proteins that were changed in infected cell lines
compared to the uninfected post treatment cell sam-
ples also showed changes in the apoptotic pathway,
however GO processes were also significantly
enhanced for transcription regulation, cell prolifera-
tion and cellular stress. No significant enriched
processes were found for the 14 significantly altered
proteins from the comparison of never-infected cells
and uninfected post treatment samples and for the 17
proteins that changed after treatment of the never-
infected cells (likely due to the small number of
proteins). The 19 overlapping proteins that were
altered between both the uninfected post treatment
and the never-infected cell lines compared to the
infected cells were enriched for the apoptotic-signal-
ing pathway as well as for cell proliferation.
Taken together, in this study we demonstrated that
mycoplasma infection of leukemic cell lines alters the
protein expression levels of individual proteins,
whereas the overall protein profiles remained rela-
tively stable. Subsequent pathway analysis of the
significantly changed proteins in the infected cells
compared to the post treatment or the never-infected
samples showed significant enrichment for apoptotic
signaling processes in particular, but also showed
changes in proteins involved in protein auto-phospho-
rylation and cell proliferation. This may suggest that
mycoplasma infection leads to an increased cellular
stress response and a reduced cell growth. Also, as
infected cells expressed lower protein levels for the
majority of the significantly altered proteins compared
to their never-infected and uninfected post treatment
counterparts, this might imply that the infected cell
lacks sufficient energy to synthesize their normal
protein levels, as they have to share their metabolism
with the mycoplasmas, but that once the mycoplasma
is eliminated their metabolism is at least partially
restored. However, a larger study should be performed
on mycoplasma infected cell cultures to assess the
effect on cell biology, as well as to assess the
additional effect of PlasmocinTM treatment on the
protein expression. In addition, because the majority
Fig. 2 Venn diagram for
the number the altered
proteins. Overlapping and
non-overlapping proteins
that were changed in each
sample comparison based on
the Wilcoxon signed-rank
test (alpha = 0.05).
Nineteen proteins were
affected between the
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of the clean counterparts of the infected cell lines
originated from different laboratories than the infected
and post-treatment samples, and were thus previously
cultured under different circumstances, a study that
will artificially infect negative cell lines to keep
culturing conditions between cell cultures stable, will
likely result in more accurate comparisons between
cell culture samples.
In order to establish clean cell cultures to make cell
line experiments more reliable and reproducible, we
strongly encourage the regular testing of cell cultures
for mycoplasma and to treat cell lines if cultures test
positive to avoid having the consequences of altered
expression of these proteins confounding the experi-
mental results. Yet, as few alterations remained
between the post treatment samples and the never-
infected samples in our cohort, and as changes in
protein expression were observed after treatment of
never-infected cells, additional cell culturing for more
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Fig. 3 Gene ontology enrichment analysis for the significantly
altered proteins. Bar graph showing the significantly enriched
Biological Processes for 44 proteins that were altered between
the infected and never-infected cell culture samples (a), the 33
proteins that were changed between the infected and post
treatment samples (b), and for the 19 proteins that were altered
in both the never-infected and the post treatment samples in
comparison to the infected cells (c). Biological processes with
an false-discovery rate corrected q-value\ 0.05 were consid-
ered significant
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treatment, or taking a clean cell line aliquot, should
also be considered.
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